Prevalence of Rest Dyspnea and Impact of Non Invasive Ventilation on Breathing Sensations in CCHS Patients
DyspnOndine
1 other identifier
observational
20
1 country
1
Brief Summary
Congenital central hypoventilation syndrome (CCHS) is a neuro-respiratory disease characterized by lifethreatening sleep-related hypoventilation involving an alteration of CO2/H+ chemosensitivity. This suggests cortical activity during awakening to maintain breathing. Cortical activity to keep breathing is usually associated with breathing discomfort ; this is the case in healthy subjects under non invasive ventilation (NIV) or with expiratory charge as well as in patients with amyotrophic lateral sclerosis. This can suggest that CCHS may be breathless at rest and this discomfort could be reduced by NIV. The objective is to evaluate dyspnea with a multi dimensional score, MDP, in CCHS patient at rest in every day life and during 1H session of NIV. The investigators will perform a prospective, including 20 CCHS patients. MDP scores will be measure before and after 1H-non invasive ventilation as well as a visual scale of 100mm in order to evaluate variation of breathing discomfort before/after NIV. The investigators expect that CCHS patients don't have rest dyspnea but NIV would improve breathing discomfort that would mean they have latent rest dyspnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2020
CompletedFirst Posted
Study publicly available on registry
June 25, 2020
CompletedStudy Start
First participant enrolled
December 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedJuly 12, 2021
July 1, 2021
10 months
May 30, 2020
July 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
"Immediate unpleasantness" corresponding to A.1 item of the multidimensional dyspnea profile
Measure MDP scores before and after NIV
Change in MDP score between baseline and after 1 hour of NIV
Study Arms (1)
CCHS
20 patients presenting with central hypoventilation syndrome during spontaneous breathing and with Non Invasive Ventilation
Interventions
Eligibility Criteria
Adults with CCHS who already require long terme NIV but not phrenic nerve stimulation
You may qualify if:
- patients with CCHS confirmed by genetic test
- patients with long term non invasive ventilation
- no recent condition that could impact breathing sensations such as infection, pulmonary embolism, heart failure
You may not qualify if:
- pregnancy
- phrenic nerve stimulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
INSERM-UPC UMR_S 1158, Service de Pneumologie et Réanimation, GH Pitié-Salpêtrière
Paris, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2020
First Posted
June 25, 2020
Study Start
December 15, 2021
Primary Completion
October 1, 2022
Study Completion
October 1, 2022
Last Updated
July 12, 2021
Record last verified: 2021-07